Destiny Wealth Partners’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,350
Closed -$16K 640
2022
Q1
$16K Hold
1,350
﹤0.01% 401
2021
Q4
$46K Hold
1,350
0.01% 328
2021
Q3
$65K Buy
+1,350
New +$62.5K 0.01% 245
2021
Q2
Sell
-1,350
Closed -$65K 385
2021
Q1
$65K Hold
1,350
0.01% 240
2020
Q4
$73K Buy
+1,350
New +$61K 0.02% 256

Other funds holding NEO

Destiny Wealth Partners's NEO Position: Q2 2022 in Review

Destiny Wealth Partners sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 1,350 shares — an estimated $16K sold.

Destiny Wealth Partners first reported a position in NEO in Q4 2020 and held it in 5 quarters. The position peaked at $73K in Q4 2020. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

  • Destiny Wealth Partners reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
  • Destiny Wealth Partners sold 1,350 NeoGenomics shares in Q2 2022, an estimated $16K.
  • Destiny Wealth Partners first reported a position in NeoGenomics in Q4 2020 and held it in 5 quarters.
  • Destiny Wealth Partners's NeoGenomics position peaked at $73K in Q4 2020.
  • 239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Destiny Wealth Partners's 13F filing for Q2 2022, filed 15 Jul 2022.